Viewing Study NCT00788658


Ignite Creation Date: 2025-12-17 @ 4:25 PM
Ignite Modification Date: 2025-12-24 @ 1:12 AM
Study NCT ID: NCT00788658
Status: COMPLETED
Last Update Posted: 2016-04-13
First Post: 2008-11-10
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Cognitive Behaviour Therapy for Patients With IBS
Sponsor: Rabin Medical Center
Organization:

Study Overview

Official Title: Cognitive Behavior Therapy (CBT) as Compared With Standard Therapy for Patients With IBS and Other Functional Gastrointestinal Disorders
Status: COMPLETED
Status Verified Date: 2016-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: EFI
Brief Summary: Irritable bowel syndrome (IBS) affects approximately 10-15% of the adult population. This condition is characterized by abdominal pain, altered bowel habit, abdominal bloating and reduced quality of life. Options for treating IBS include pharmacotherapy, psychotherapy, hypnotherapy and cognitive behavior therapy (CBT). Available data on the effectiveness of CBT in IBS patients in Israel are scarce.

The aim of the present study is to assess effectiveness of CBT as compared with standard therapy for IBS patients in Israel The course of CBT consisted of up to six 40 min sessions, and included education about IBS and techniques to reduce focusing on symptoms and to manage stress.Standard therapy includs life style modifications.

The primary outcome measure was the score on a symptom-severity scale specific to IBS.
Detailed Description: Symptomatic treatment of patients would not be modified

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: